Abstract
To report an economic analysis of the Australian intrapartum fetal pulse oximetry (FPO) multicentre randomized controlled trial (the FOREMOST trial), which examined whether adding FPO to conventional cardiotocographic (CTG) fetal monitoring (intervention group) was a cost-effective intervention in reducing the operative delivery rate for non-reassuring fetal status, compared to CTG alone (control group).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
